We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.08B
AUM Growth
-$19.5M
Cap. Flow
-$53.5M
Cap. Flow %
-2.57%
Top 10 Hldgs %
31.15%
Holding
437
New
21
Increased
82
Reduced
223
Closed
10

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$11.2M
2
BMY icon
Bristol-Myers Squibb
BMY
+$9.6M
3
DD icon
DuPont de Nemours
DD
+$7.73M
4
PAAS icon
Pan American Silver
PAAS
+$3.51M
5
DIS icon
Walt Disney
DIS
+$3.12M

Top Sells

Rank Stock Value
1
HXL icon
Hexcel
HXL
+$32.6M
2
PXD
Pioneer Natural Resource Co.
PXD
+$9.53M
3
GILD icon
Gilead Sciences
GILD
+$8.13M
4
ORCL icon
Oracle
ORCL
+$7.51M
5
F icon
Ford
F
+$6.95M

Sector Composition

Rank Sector Weight
1 Healthcare 17.66%
2 Energy 16.26%
3 Financials 14.09%
4 Technology 10.98%
5 Industrials 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTE icon
201
TotalEnergies
TTE
$193B
$1.21M 0.06%
21,655
-1,884
-8% -$103K
DELL icon
202
Dell
DELL
$283B
$1.2M 0.06%
46,531
-596
-1% -$18.6K
CP icon
203
Canadian Pacific Kansas City
CP
$82B
$1.17M 0.06%
24,945
-950
-4% -$42.4K
GLW icon
204
Corning
GLW
$126B
$1.16M 0.06%
34,855
-1,450
-4% -$46.5K
VCEL icon
205
Vericel Corp
VCEL
$2.3B
$1.15M 0.06%
60,892
-524
-0.9% -$8.94K
WBC
206
DELISTED
WABCO HOLDINGS INC.
WBC
$1.15M 0.06%
8,651
-32,447
-79% -$4.28M
CSBR icon
207
Champions Oncology
CSBR
$85.1M
$1.14M 0.06%
146,046
-12,602
-8% -$111K
BP icon
208
BP
BP
$113B
$1.13M 0.05%
27,450
TRI icon
209
Thomson Reuters
TRI
$39.4B
$1.09M 0.05%
16,076
-1,065
-6% -$70.5K
BNY
210
Bank of New York Mellon
BNY
$108B
$1.08M 0.05%
24,514
+14,904
+155% +$700K
NWN icon
211
Northwest Natural Holdings
NWN
$2.17B
$1.08M 0.05%
15,500
-23
-0.1% -$1.56K
KHC icon
212
Kraft Heinz
KHC
$30.4B
$1.07M 0.05%
34,610
-4,349
-11% -$137K
HON icon
213
Honeywell
HON
$77.1B
$1.07M 0.05%
6,511
-87
-1% -$13.8K
MU icon
214
Micron Technology
MU
$1.04T
$1.07M 0.05%
27,723
+1,017
+4% +$38.7K
ETN icon
215
Eaton
ETN
$157B
$1.07M 0.05%
12,800
RPM icon
216
RPM International
RPM
$13.7B
$1.06M 0.05%
17,400
LOW icon
217
Lowe's Companies
LOW
$116B
$1.05M 0.05%
10,393
+38
+0.4% +$4.01K
WTRG icon
218
Essential Utilities
WTRG
$11.2B
$1.04M 0.05%
25,076
WFC.PRL icon
219
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$1.02M 0.05%
751
GS icon
220
CALL
Goldman Sachs
GS
$313B
$1.02M 0.05%
5,000
AZN icon
221
AstraZeneca
AZN
$263B
$1.02M 0.05%
12,333
-592
-5% -$46.4K
SMED
222
DELISTED
Sharps Compliance Corp
SMED
$1.01M 0.05%
283,983
-10,836
-4% -$37.5K
OGS icon
223
ONE Gas
OGS
$5.05B
$990K 0.05%
10,968
-12
-0.1% -$1.06K
NVO
224
Novo Nordisk
NVO
$216B
$983K 0.05%
38,512
-9,780
-20% -$242K
CCEP icon
225
Coca-Cola Europacific Partners
CCEP
$46.5B
$977K 0.05%
17,300
-98
-0.6% -$5.36K

Similar funds

Ingalls & Snyder LLC's Q2 2019 Portfolio in Review

As of Q2 2019, Ingalls & Snyder LLC held 437 positions worth $2.08B, down 0.93% from $2.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ingalls & Snyder LLC's Q2 2019 filing shows 21 new, 82 increased, 223 reduced and 10 closed positions. Its largest new stake was Pan American Silver: 291,400 shares worth $3.76M. The largest sale was Hexcel, an estimated $32.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Energy and Financials.

  • Ingalls & Snyder LLC's largest Q2 2019 buy was Pan American Silver: 291,400 shares worth $3.76M.
  • Ingalls & Snyder LLC added most to Citigroup in Q2 2019, an estimated $11.2M increase.
  • Ingalls & Snyder LLC's biggest Q2 2019 reduction was Hexcel, cutting an estimated $32.6M.
  • Ingalls & Snyder LLC fully exited Ford in Q2 2019, selling an estimated $6.95M.
  • Ingalls & Snyder LLC's ten largest holdings make up 31% of its $2.08B portfolio in Q2 2019.
  • Ingalls & Snyder LLC opened 21 new positions and closed 10 in Q2 2019.
  • Ingalls & Snyder LLC's portfolio value fell 0.93% quarter-over-quarter to $2.08B.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2019, filed 11 Jul 2019.